Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORAL: Partial Oral Antibiotic Treatment for Brain Abscess
NCT04140903Phase 4Recruiting
- Start
- Nov 2020
- Primary completion
- Aug 2028
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in brain abscess (2 arms). Primary endpoint: Treatment failure at 6 months. Started Nov 2020; status: recruiting.
02
Conditions
brain abscess
Beyond the preview
Go deeper on NCT04140903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04140903.